161 related articles for article (PubMed ID: 6452856)
1. the role of autoantibody and immune complexes in the pathogenesis of Guillain-Barré syndrome.
Cook SD; Dowling PC
Ann Neurol; 1981; 9 Suppl():70-9. PubMed ID: 6452856
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG, and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Yuki N; Tagawa Y; Handa S
J Neuroimmunol; 1996 Oct; 70(1):1-6. PubMed ID: 8862128
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy.
van Doorn PA; Brand A; Vermeulen M
Neurology; 1987 Nov; 37(11):1798-802. PubMed ID: 3670618
[TBL] [Abstract][Full Text] [Related]
4. Activation of terminal components of complement in patients with Guillain-Barré syndrome and other demyelinating neuropathies.
Koski CL; Sanders ME; Swoveland PT; Lawley TJ; Shin ML; Frank MM; Joiner KA
J Clin Invest; 1987 Nov; 80(5):1492-7. PubMed ID: 3680509
[TBL] [Abstract][Full Text] [Related]
5. In vitro demyelination by serum antibody from patients with Guillain-Barré syndrome requires terminal complement complexes.
Sawant-Mane S; Clark MB; Koski CL
Ann Neurol; 1991 Apr; 29(4):397-404. PubMed ID: 1718212
[TBL] [Abstract][Full Text] [Related]
6. Humoral mechanisms in immune neuropathies.
Koski CL
Neurol Clin; 1992 Aug; 10(3):629-49. PubMed ID: 1501599
[TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome: an ultrastructural study of peripheral nerve in 65 patients.
Brechenmacher C; Vital C; Deminiere C; Laurentjoye L; Castaing Y; Gbikpi-Benissan G; Cardinaud JP; Favarel-Garrigues JP
Clin Neuropathol; 1987; 6(1):19-24. PubMed ID: 3552352
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Maimone D; Annunziata P; Simone IL; Livrea P; Guazzi GC
J Neuroimmunol; 1993 Aug; 47(1):55-61. PubMed ID: 8376548
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome: demonstration of antibodies to peripheral nerve tissue.
Nyland H; Aarli JA
Acta Neurol Scand; 1978 Jul; 58(1):35-43. PubMed ID: 707033
[TBL] [Abstract][Full Text] [Related]
10. Characterization of complement-fixing antibodies to peripheral nerve myelin in Guillain-Barré syndrome.
Koski CL
Ann Neurol; 1990; 27 Suppl():S44-7. PubMed ID: 2194426
[TBL] [Abstract][Full Text] [Related]
11. The clinical effect and the effect on serum IgG antibodies to peripheral nerve tissue of plasma exchange in patients wit Guillain-Barré syndrome.
Vedeler CA; Nyland H; Fagius J; Osterman PO; Matre R; Aarli JA; Janzen RW; Jacobsen H; Skre H
J Neurol; 1982; 228(1):59-64. PubMed ID: 6184459
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to peripheral nerve tissue in sera from patients with acute Guillain-Barré syndrome demonstrated by a mixed haemagglutination technique.
Vedeler CA; Nyland H; Matre R
J Neuroimmunol; 1982 Jun; 2(3-4):209-14. PubMed ID: 7085862
[TBL] [Abstract][Full Text] [Related]
13. [New aspects of the pathogenesis and therapy of Guillain-Barré syndrome and chronic polyneuritis].
Hartung HP; Heininger K; Toyka KV
Nervenarzt; 1990 Apr; 61(4):197-207. PubMed ID: 2191228
[TBL] [Abstract][Full Text] [Related]
14. Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation.
Koski CL; Humphrey R; Shin ML
Proc Natl Acad Sci U S A; 1985 Feb; 82(3):905-9. PubMed ID: 3856240
[TBL] [Abstract][Full Text] [Related]
15. Serum antibodies to peripheral nerve antigens in Guillain-Barré syndrome.
Negishi T; Yamashita T; Nomura K; Hosokawa T; Ohno R; Hamaguchi K; Uyemura K
Ann N Y Acad Sci; 1988; 540():376-7. PubMed ID: 2462815
[No Abstract] [Full Text] [Related]
16. Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome.
Willison HJ; O'Hanlon G; Paterson G; O'Leary CP; Veitch J; Wilson G; Roberts M; Tang T; Vincent A
J Infect Dis; 1997 Dec; 176 Suppl 2():S144-9. PubMed ID: 9396699
[TBL] [Abstract][Full Text] [Related]
17. Serum antibodies to heparan sulfate glycosaminoglycans in Guillain-Barré syndrome and other demyelinating polyneuropathies.
Pestronk A; Choksi R; Yee WC; Kornberg AJ; Lopate G; Trotter J
J Neuroimmunol; 1998 Nov; 91(1-2):204-9. PubMed ID: 9846837
[TBL] [Abstract][Full Text] [Related]
18. Plasma exchange in patients with Guillain-Barré syndrome: clinical improvement in patients with serum IgG antibodies to peripheral nerve tissue.
Nyland H; Vedeler CA; Matre R; Halvorsen K; Fagius J; Osterman PO; Janzen RW; Skre H
Int J Artif Organs; 1984 May; 7(3):133-6. PubMed ID: 6735503
[TBL] [Abstract][Full Text] [Related]
19. Immune reactions to P2 protein in human inflammatory demyelinative neuropathies.
Zweiman B; Rostami A; Lisak RP; Moskovitz AR; Pleasure DE
Neurology; 1983 Feb; 33(2):234-7. PubMed ID: 6600513
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammatory demyelinating polyneuropathy.
Rizzuto N; Simonati A
Int J Tissue React; 1985; 7(6):521-6. PubMed ID: 4086221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
